Adebelimab Injection

DRUG3 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Xian-Jun Yu

Conditions

Advanced Solid TumorsRecurrent or Metastatic Cervical CancerTumor, Solid

Phase 1

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

RecruitingNCT06859775

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Recurrent or Metastatic Cervical Cancer

Start: 2025-04-25End: 2027-01-31Target: 100Updated: 2025-06-06

Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors

RecruitingNCT07348042

Xian-Jun YuTumor, Solid

Start: 2025-09-07End: 2027-12-31Target: 198Updated: 2026-01-16

Phase 2

A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors

RecruitingNCT06895928

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2025-03-28End: 2028-12-31Target: 400Updated: 2025-04-22